Stem cell transplant comparison for T-cell leukemia
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study compares two types of stem cell transplants for adults with T-ALL: one using a half-matched donor alone, and one using a half-matched donor plus umbilical cord blood. The goal is to see which approach gives better results with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have acute T-cell lymphoblastic leukemia (T-ALL).
- You've had testing to look for tiny bits of leukemia left after treatment (minimal residual disease).
- You are willing to get a stem cell transplant from a half-matched family donor (haploidentical).
- You are physically well enough to get out of bed and care for yourself most of the day (ECOG 0-3).
- You have not had a stem cell transplant or CAR T-cell therapy before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a newer type of stem cell transplant (using special cells) to the standard method for children who need a half-matched donor. It aims to see if the new approach is safer and works as well.
This trial compares two chemotherapy conditioning regimens (BuCy and TBICy) used before a stem cell transplant for patients with T-cell acute lymphoblastic leukemia. The goal is to see which regimen leads to better outcomes after the transplant.
This trial combines a special type of stem cell transplant (using half-matched donor cells) with CAR-T therapy and memory T-cell infusions for people with acute leukemia that has not responded to treatment or has come back. The goal is to provide a curative treatment for those who do not have a fully matched donor.
This study compares two types of stem cell transplants (from a donor or your own cells) for people with certain T-cell lymphomas who had only a partial response to first chemotherapy. It aims to see which approach may work better.
This trial tests a new way to do a stem cell transplant for people with hard-to-treat blood cancers. It combines a half-matched family donor (haploidentical) with a cord blood unit to help the transplant work better.
This trial tests a stem cell transplant using a half-matched family donor for children with acute lymphoblastic leukemia (ALL) that is in remission. It compares two different types of radiation conditioning to prepare the body for the new cells, with the goal of improving outcomes.
Hear when a new Haploidentical Hematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.